2025-10-30T10:17:43-05:00 2024-12-31 231406493 MORISON COGEN LLP 484 NORRISTOWN RD STE 100 BLUE BELL PA 19422 990 2024-01-01 271536314 NCCN FOUNDATION NCCN 2156900300 3025 CHEMICAL ROAD 100 PLYMOUTH MEETING PA 19462 EILEEN BOSCIA CHIEF FINANCIAL OFFICER 2156900300 2025-10-30 1 0 JOSEPH M KISTNER CPA P00157086 2674403000 2024 2025-03-06 01:10:19Z CRYSTAL S DENLINGER MD 3025 CHEMICAL ROAD 100 PLYMOUTH MEETING PA 19462 3897459 0 X WWW.NCCN.ORG X 2009 DE THROUGH PHILANTHROPY, THE NCCN FOUNDATION EMPOWERS PEOPLE THROUGH KNOWLEDGE AND ADVANCES THE MISSION OF NCCN TO DEFINE AND ADVANCE QUALITY, EFFECTIVE, EQUITABLE, AND ACCESSIBLE CANCER CARE AND PREVENTION SO ALL PEOPLE CAN LIVE BETTER LIVES. 11 11 0 0 0 0 2927399 3355941 222926 293405 173437 242510 5866 5603 3329628 3897459 640833 856428 0 0 0 0 0 0 0 1805654 1600018 2446487 2456446 883141 1441013 8210829 9542998 543115 434271 7667714 9108727 THROUGH PHILANTHROPY, THE NCCN FOUNDATION EMPOWERS PEOPLE THROUGH KNOWLEDGE AND ADVANCES THE MISSION OF NCCN TO DEFINE AND ADVANCE QUALITY, EFFECTIVE, EQUITABLE, AND ACCESSIBLE CANCER CARE AND PREVENTION SO ALL PEOPLE CAN LIVE BETTER LIVES. 0 0 1583076 299008 TRANSLATE THE NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY FOR CLINICAL PROVIDERS INTO GUIDELINES WRITTEN FOR A PATIENT AUDIENCE. DISTRIBUTION OF THESE NCCN GUIDELINES FOR PATIENTS. 869478 856428 DEVELOP A RESEARCH GRANT PROGRAM TO ENCOURAGE AND ASSIST YOUNG INVESTIGATORS, NURSES, AND OTHERS TO CONDUCT INNOVATIVE AND COLLABORATIVE RESEARCH IN CLINICAL ONCOLOGY AT NCCN MEMBER INSTITUTIONS. 2452554 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 15 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 11 11 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 AL AK AZ AR CA CO CT FL GA HI IL KS KY LA ME MD MA MI MS MN MO NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X EILEEN BOSCIA 2156900300 3025 CHEMICAL ROAD SUITE 100 PLYMOUTH MEETING PA 19462 GENA COOK CHAIR 1.00 X 0 0 0 HEATHER J KOPECKY PHD MBA VICE-CHAIR 1.00 X 0 0 0 ANGELIQUE L RICHARD PHD RN SECRETARY 1.00 X 0 0 0 PATRICK J O'BRIEN MBA TREASURER 1.00 X 0 0 0 AL B BENSON III MD DIRECTOR 1.00 X 0 0 0 MARC SAMUELS JD MPH DIRECTOR 1.00 X 0 0 0 SUSAN STEIN MPH DIRECTOR 1.00 X 0 0 0 DENISE PORTNER DIRECTOR 1.00 X 0 0 0 CHRISTOPHER PRICE DIRECTOR 1.00 X 0 0 0 JOHN W SWEETENHAM DIRECTOR 1.00 X 0 0 0 TAMAR THOMPSON DIRECTOR 1.00 X 0 0 0 CRYSTAL DENLINGER MD CHIEF EXECUTIVE OFFICER 2.00 40.00 X 0 679441 49335 GARY WEYHMULLER CHIEF OPERATING OFFICER 2.00 40.00 X 0 629399 65647 EILEEN BOSCIA CHIEF FINANCIAL OFFICER 2.00 40.00 X 0 359832 50239 PATRICK DELANEY EXECUTIVE DIRECTOR 40.00 4.00 X 0 221100 51646 BETH GAFFNEY VP - US & GLOBAL BUSINESS 2.00 40.00 X 0 282409 70766 JENNIFER TREDWELL SENIOR VP, MARKETING & COM 2.00 40.00 X 0 244843 61548 0 2417024 349181 0 0 1 0 0 3355941 3355941 TRANSLATIONS 900099 150243 150243 PERMISSION FEES 900099 122657 122657 PATIENT GUIDELINE DIST 900099 20505 20505 293405 242510 242510 5603 5603 3897459 299008 0 242510 X 856428 856428 1531475 1531475 9536 9536 3157 3157 11050 11050 HONORARIA 17000 17000 PRINTING 12908 12908 ART 7450 7450 FEES 3892 3892 3550 3550 2456446 2452554 3892 0 2407418 1402402 5674424 7416934 128537 723662 450 0 8210829 9542998 31529 22400 147764 127478 363822 284393 543115 434271 X 4803657 5271566 2864057 3837161 7667714 9108727 8210829 9542998 1441013 0 X X 0 1 X 1 0 X 3927775 3395934 2750797 2927399 3355941 16357846 3927775 3395934 2750797 2927399 3355941 16357846 5612071 10745775 10253 4293 7167 179303 248113 449129 92795 297511 517206 222926 293405 1423843 18230818 0.58940 0.55220 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 RELATED PARTY ACCOUNTS PAYABLE 284393 284393 5508446 1610987 1610987 3897459 0 3897459 4067433 1610987 1610987 2456446 0 2456446 1 BECKMAN RESEARCH INSTITUTE OF CITY OF HOPE CITY OF HOPE 1500 E DURATE ROAD DUARTE CA 910103000 953432210 501 (C)(3) 50000 0 RESEARCH CLEVELAND CLINIC FOUNDATION 9500 EUCLID AVENUE CLEVELAND OH 44195 340714585 501 (C)(3) 150000 0 RESEARCH HEALTH RESEARCH INC ELM AND CARLTON STREETS BUFFALO NY 14263 141402155 501 (C)(3) 14250 0 RESEARCH INSTITUTE FOR CANCER RESEARCH 604 COTTMAN AVENUE CHELTENHAM PA 19012 236296135 501 (C)(3) 100000 0 RESEARCH MEMORIAL SLOAN KETTERING CANCER CENTER 1275 YORK AVENUE NEW YORK NY 10065 131624182 501 (C)(3) 50000 0 RESEARCH THE OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER 1960 KENNY ROAD COLUMBUS OH 43221 316401599 501 (C)(3) 100000 0 RESEARCH UNIVERSITY OF MICHIGAN 3003 S STATE STREET ANN ARBOR MI 48104 386006309 501 (C)(3) 99905 0 RESEARCH REGENTS OF UNIV CALIFORNIA SF 1855 FOLSOM ST STE 425 SAN FRANCISCO CA 941034249 946036493 501 (C)(3) 50000 0 RESEARCH THE BOARD OF REGENTS OF THE UNIVERSITY IF WISCONSIN SYSTEM 21 N PARK ST SUITE 6301 MADISON WI 537151218 396006492 501 (C)(3) 50000 0 RESEARCH UNIVERSITY OF COLORADO PO BOX 910238 DENVER CO 802910238 846000555 501 (C)(3) 44665 0 RESEARCH UNIVERSITY OF CHICAGO MEDICINE COMPREHENSIVE CANCER CENTER 6054 DREXEL AVENUE SUITE 200 CHICAGO IL 60637 362177139 501 (C)(3) 50000 0 RESEARCH THE UNIVERSITY OF TEXAS 1515 HOLCOMBE AVENUE UNIT 176 HOUSTON TX 77030 746001118 501 (C)(3) 50000 0 RESEARCH UNIVERSITY OF ALABAMA AT BIRMINGHAM 1720 2ND AVE S BIRMINGHAM AL 35294 636005396 501 (C)(3) 50000 0 RESEARCH 15 PART I, LINE 2 NCCN FOUNDATION HOLDS AN ANNUAL COMPETITIVE YOUNG INVESTIGATOR AWARD (YIA) PROGRAM OPEN TO NOMINATED INVESTIGATORS AT THE 33 NCCN MEMBER INSTITUTIONS. IN COLLABORATION WITH THE NCCN FOUNDATION, THE NCCN ONCOLOGY RESEARCH PROGRAM (ORP) PROVIDES OVERSIGHT OF THIS PROGRAM AND THEIR STANDARDS ARE USED BY THE YIA GRANTS SCIENTIFIC REVIEW COMMITTEE TO REVIEW AND SCORE THE YIA PROPOSALS. THE FUNDED PROJECTS ARE APPROVED FOR TWO-YEAR TERMS AND ARE MANAGED BY THE ORP. INITIAL FUNDING IS PROVIDED BY THE NCCN FOUNDATION TO AWARDEES' INSTITUTIONS UPON THE RECEIPT OF APPLICABLE DOCUMENTS, WHICH MAY INCLUDE INSTITUTIONAL REVIEW BOARD (IRB) APPROVAL DOCUMENTATION, A SIGNED TERM & CONDITIONS AGREEMENT ATTESTING THAT THE AWARDEES WILL ABIDE BY THE SPECIFIC TERMS OF THE AWARD, AN IRB-APPROVED PROTOCOL OR, IN THE CASE OF IRB EXEMPT RESEARCH, A LETTER OF EXEMPTION FROM THE IRB, A RESEARCH PROJECT PLAN, HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT (HIPAA) DOCUMENTS RELATED TO THE PROJECT, A DATA MONITORING PLAN, PHYSICIAN PAYMENT TRANSPARENCY PROGRAM (SUNSHINE ACT) FORM, AND NCCN FINANCIAL CERTIFICATION/DISCLOSURE FORMS. THE SCOPE AND NATURE OF STUDIES TO BE PERFORMED BY AWARDEES ARE IN ACCORDANCE WITH THE APPROVED PROTOCOLS DEVELOPED BY THE AWARDEES AND CONSISTENT WITH THE PROPOSALS SUBMITTED TO AND APPROVED BY THE YIA GRANTS SELECTION REVIEW COMMITTEE. SECOND-YEAR FUNDING IS PROVIDED TO THE AWARDEES' INSTITUTIONS UPON RECEIPT AND SATISFACTORY REVIEW OF AN ANNUAL PROGRESS REPORT, AN ANNUAL FINANCIAL REPORT, AND DOCUMENTATION OF CONTINUED APPLICABLE INSTITUTIONAL APPROVAL WITH THE FINAL GRANT PAYMENT PROVIDED UPON RECEIPT OF A COMPLETED GRANT RECONCILIATION AND FINAL STUDY REPORT. IF THE AWARDEE FAILS TO COMPLY WITH THE TERMS AND CONDITIONS OF THE AWARD AGREEMENT, OR OTHER CONTINGENCIES RECOMMENDED BY THE YIA GRANTS SCIENTIFIC REVIEW COMMITTEE, UNSPENT AWARD FUNDING MUST BE RETURNED WITHIN 60 DAYS TO NCCN FOUNDATION BY THE INSTITUTION. DURING THE TERM OF THE GRANT, INVESTIGATORS REPORT TO THE NCCN ORP ON AT LEAST A QUARTERLY BASIS REGARDING THE STATUS AND PROGRESS OF THE FUNDED STUDIES. REPORTS INCLUDE AN ASSESSMENT OF OVERALL STUDY PROGRESS. X X X 0 0 0 0 0 0 0 0 0 CRYSTAL DENLINGER MD CHIEF EXECUTIVE OFFICER 0 619441 0 60000 0 0 0 34500 0 14835 0 728776 0 0 GARY WEYHMULLER CHIEF OPERATING OFFICER 0 574279 0 55120 0 0 0 34500 0 31147 0 695046 0 0 EILEEN BOSCIA CHIEF FINANCIAL OFFICER 0 327591 0 32241 0 0 0 34500 0 15739 0 410071 0 0 BETH GAFFNEY VP - US & GLOBAL BUSINESS 0 256159 0 26250 0 0 0 26755 0 44011 0 353175 0 0 JENNIFER TREDWELL SENIOR VP, MARKETING & COM 0 222785 0 22058 0 0 0 23119 0 38429 0 306391 0 0 PATRICK DELANEY EXECUTIVE DIRECTOR 0 200467 0 20633 0 0 0 13635 0 38011 0 272746 0 0 FORM 990, PART VI, SECTION B, LINE 11B NCCN FOUNDATION PROVIDES A DRAFT COPY OF THE FORM 990 TO THE FINANCE COMMITTEE OF THE BOARD OF DIRECTORS FOR ITS REVIEW AND APPROVAL PRIOR TO FILING THE RETURN. FORM 990, PART VI, SECTION B, LINE 12C NCCN FOUNDATION REQUIRES OFFICERS, DIRECTORS, AND KEY EMPLOYEES TO ANNUALLY COMPLETE A CONFLICT OF INTEREST QUESTIONNAIRE. THIS QUESTIONNAIRE SHALL BE UPDATED AS NECESSARY TO REFLECT CHANGES DURING THE COURSE OF THE YEAR. COMPLETED QUESTIONNAIRES SHALL BE AVAILABLE FOR INSPECTION BY ANY BOARD MEMBER AND MAY BE REVIEWED BY NCCN'S LEGAL COUNSEL. SENIOR NCCN STAFF REVIEW THE CONFLICT OF INTEREST FORMS ANNUALLY, PROVIDE A REPORT TO THE EXECUTIVE COMMITTEE AND TAKE CORRECTIVE ACTION IF NEEDED. FORM 990, PART VI, SECTION B, LINE 15 THE CHIEF EXECUTIVE OFFICER (CEO) IS A FULL-TIME EMPLOYEE OF NCCN AND A PORTION OF THEIR TIME IS ALLOCATED TO THE FOUNDATION. THE FOUNDATION RELIES ON NCCN FOR DETERMINATION AND REVIEW OF COMPENSATION. THE COMPENSATION OF NCCN'S CEO IS REVIEWED PERIODICALLY BY AN INDEPENDENT ORGANIZATION ENGAGED BY THE CHAIR OF NCCN'S BOARD OF DIRECTORS TO CONDUCT A SALARY COMPARABILITY STUDY AND SURVEY. A SALARY COMPARABILITY STUDY AND SURVEY WERE COMPLETED DURING 2024. THE INFORMATION FROM THE SURVEY CONDUCTED BY THE INDEPENDENT ORGANIZATION IS FORWARDED TO NCCN'S EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS FOR THEIR REVIEW. EACH YEAR, THE EXECUTIVE COMMITTEE OF NCCN'S BOARD OF DIRECTORS RECEIVES INFORMATION REGARDING THE CEO'S PAST SALARY HISTORY AS WELL AS THE CEO'S ACCOMPLISHMENTS. NCCN'S EXECUTIVE COMMITTEE SCHEDULES A CONFERENCE CALL TO REVIEW THIS INFORMATION AND TO DISCUSS RECOMMENDATIONS FOR THE CEO'S SALARY AND BONUS FOR THE UPCOMING YEAR. FORM 990, PART VI, SECTION B, LINE 15B THE CHIEF OPERATING OFFICER (COO) AND CHIEF FINANCIAL OFFICER (CFO) ARE FULL-TIME EMPLOYEES OF NCCN AND A PORTION OF THEIR TIME IS ALLOCATED TO THE FOUNDATION. THE FOUNDATION RELIES ON NCCN FOR DETERMINATION AND REVIEW OF COMPENSATION. THE COMPENSATION OF NCCN'S COO AND CFO IS REVIEWED PERIODICALLY BY AN INDEPENDENT ORGANIZATION ENGAGED BY THE CEO OF NCCN. A SALARY COMPARABILITY STUDY AND SURVEY WERE COMPLETED DURING 2024. THE ORGANIZATION CONDUCTS A SALARY COMPARABILITY STUDY AND SURVEY FOR COMPARABLE POSITIONS IN SIMILAR ORGANIZATIONS. THE NCCN CEO REVIEWS THE SALARY STUDY AND SURVEY TO DETERMINE THE COMPENSATION FOR THE ABOVE KEY EMPLOYEES OF NCCN. FORM 990, PART VI, SECTION C, LINE 19 NCCN FOUNDATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 11G CONSULTING: PROGRAM SERVICE EXPENSES 1,358,875. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,358,875. TRANSLATION SERVICES: PROGRAM SERVICE EXPENSES 172,600. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 172,600. 990, PART IX ALL OF NCCN FOUNDATION'S FUNDRAISING EXPENSES AND THE MAJORITY OF THE MANAGEMENT AND GENERAL EXPENSES FOR 2024 WERE COVERED THROUGH IN-KIND DONATIONS TOTALING $1,610,987 FROM NATIONAL COMPREHENSIVE CANCER NETWORK. FORM 990, PART XII, QUESTION 2C: THE FINANCE COMMITTEE ASSUMES RESPONSIBILITY FOR THE OVERSIGHT OF THE AUDIT AND SELECTION OF AN INDEPENDENT ACCOUNTANT. NATIONAL COMPREHENSIVE CANCER NETWORK 3025 CHEMICAL ROAD SUITE 100 PLYMOUTH MEETING PA 19462 232818395 CHARITABLE DE 501(C)(3) LINE 7 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 1 0 0 NATIONAL COMPREHENSIVE CANCER NETWORK M 1358875 FMV NATIONAL COMPREHENSIVE CANCER NETWORK O 1270761 FMV NATIONAL COMPREHENSIVE CANCER NETWORK Q 340226 FMV PART V LINE 2(3), COLUMN C PROFESSIONAL FEES $177,550 TRAVEL AND MEETINGS 105,541 MARKETING AND PUBLIC RELATIONS 20,308 OTHER EXPENSE 19,386 OFFICE EXPENSES 15,058 SUPPLIES AND PRINTING 2,300 TELEPHONE 83 TOTAL PART V - LINE 2(3) $340,226